Optimizing drug safety
monitoring to enhance patient safety and achieve better health outcomes.
About the Monitoring Medicines
‘Monitoring Medicines’ is a project, running for 42 months, funded by the Seventh Framework Programme (FP-7) of the Research Directorate of the European Commission (EC). The agreement between the EC and the Uppsala Monitoring Centre came into force on 1 September 2009.
What is Monitoring Medicines?
The four themes are:
• Strengthening consumer reporting
• Pharmacovigilance centres collecting problems related to inappropriate drug use
• Better use of existing global pharmacovigilance data
• Developing active and focussed pharmacovigilance systems.